UK moves to boost patient influence on health service policy:
This article was originally published in Clinica
Executive Summary
Patient influence on the UK's increasingly decentralised health service policy is set to get a boost from the creation of the Patient and Public Involvement Resource Centre. From June 1, this national initiative will seek to "promote the value of involving people [in local services] and will work with NHS organisations, staff and patients". The move further underlines the opportunities and indeed importance for the medical technology industry in increasingly targeting their product information campaigns at the public. The Department of Health announced the project yesterday at the Patient Involvement, Empowerment and Information conference in London, after signing the contract for the service. The centre will be operated by a consortium comprising the University of Warwick, the Centre for Public Scrutiny and the Long-term Medical Conditions Alliance.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.